# Blue Light Photobiomodulation Therapy on Neuroischemic Patients

> **NCT04831606** · NA · TERMINATED · sponsor: **Emoled** · enrollment: 21 (actual)

## Conditions studied

- Diabetic Foot Ulcer

## Interventions

- **PROCEDURE:** debridement
- **DEVICE:** Offloading
- **DEVICE:** Advanced dressing
- **DEVICE:** Blue Light Photobiomodulation

## Key facts

- **NCT ID:** NCT04831606
- **Lead sponsor:** Emoled
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-07-31
- **Primary completion:** 2024-07-01
- **Final completion:** 2024-07-01
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** very low enrollment rate
- **Last updated:** 2024-11-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04831606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04831606, "Blue Light Photobiomodulation Therapy on Neuroischemic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04831606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*